ScreenerHero

0RCQ Nicox S.A.

LSE · GB · Healthcare · Biotechnology · nicox.com
0.3128EUR-0.95%Mkt Cap: —P/E: —

Nicox S.A., together with its subsidiaries, operates as an ophthalmology company in France and internationally. It develops solutions to preserving vision and improve eye health. The company's lead product candidate is N…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap—
Enterprise Value26.18M USD
Revenue (TTM)18.23M USD
Gross Profit7.11M USD
Net Income (TTM)-2.62M USD
Revenue/Share0.21 EUR
Last Price0.3128 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees10
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA3.63
EV/Revenue1.44
P/S—
P/B4.64
EPS (TTM)-1.17
EPS (Forward)—
52W Range
0.282011% of range0.5655
52W High0.5655 EUR
52W Low0.2820 EUR
Profitability
Gross Margin38.99%
Oper. Margin77.28%
EBITDA Margin39.58%
Profit Margin-14.39%
ROE-51.16%
ROA23.81%
Growth
Revenue Growth751.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-4.07M USD
Net Debt/EBITDA-0.56
Balance Sheet
Debt/Equity6.71
Current Ratio4.17
Quick Ratio3.00
Book Value/Sh0.07 EUR
Cash/Share0.05 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split0.2:1
Split DateDec 3, 2015
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.29.59M
Float85.07M
Insiders5.14%
Institutions1.60%
Technical
SMA 500.4110 (-23.9%)
SMA 2000.4858 (-35.6%)
Beta0.53
S&P 52W Chg15.78%
Avg Vol (30d)7.87K
Avg Vol (10d)22
Technical Indicators
RSI (14)28.4
MACD-0.0154
MACD Signal-0.0128
MACD Hist.-0.0026
BB Upper0.3991 EUR
BB Middle0.3466 EUR
BB Lower0.2942 EUR
BB Width30.25%
ATR (14)0.0070 EUR
Vol Ratio (20d)0.02x